(R)-Methanandamide and 9 -tetrahydrocannabinol-induced operant rate decreases in rats are not readily antagonized by SR-141716A

By Jarbe T.U.C.   Lamb R.J.   Liu Q.   Makriyannis A.  

European Journal of Pharmacology, Vol. 466, Iss. 1, 2003-04 ,pp. : 121-127

Elsevier

Access to resources Recommend Favorite

Discriminative stimulus effects in rats of SR-141716 (rimonabant), a cannabinoid CB₁ receptor antagonist

By Järbe Torbjörn   Harris Michele   Li Chen   Liu Qian   Makriyannis Alexandros  

Psychopharmacology, Vol. 177, Iss. 1-2, 2004-12 ,pp. : 35-45

Springer Publishing Company

Access to resources Recommend Favorite

Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats

By Rowland Neil   Mukherjee Monica   Robertson Kimberly  

Psychopharmacology, Vol. 159, Iss. 1, 2001-12 ,pp. : 111-116

Springer Publishing Company

Access to resources Recommend Favorite

Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A

By Aceto M.D.   Scates S.M.   Lowe J.A.   Martin B.R.  

European Journal of Pharmacology, Vol. 282, Iss. 1, 1995-08 ,pp. : 1-2

Elsevier

Access to resources Recommend Favorite

Behavioral mechanisms underlying inhibition of food-maintained responding by the cannabinoid receptor antagonist/inverse agonist SR141716A

By De Vry J.   Schreiber R.   Eckel G.   Jentzsch K.R.  

European Journal of Pharmacology, Vol. 483, Iss. 1, 2004-01 ,pp. : 55-63

Elsevier

Access to resources Recommend Favorite